• Home
  • The Re-emergence of Psychedelics in Psychiatry

The Re-emergence of Psychedelics in Psychiatry

  • 03/29/2024
  • 6:30 PM - 8:00 PM
  • Cleveland Psychoanalytic Center 2460 Fairmount Blvd #312 Cleveland Heights, OH 44106

Registration


Registration is closed

A Scientific Meeting presented by Anne Harrington, PhD

Event Price: Event is free. Optional CE fee is $10 members, $25 non-members. Students receive free CEs.

Light cocktail reception 6 - 6:30 p.m. at the Center before the presentation.

Continued Education (CEU/CME): 1.5 credits

Attendance: This is a hybrid event - in person and online attendance is available.


In the 1940s, the drug company Sandoz sponsored a study of LSD at the University of Zurich which came to the conclusion that this was a drug that made normal people temporarily schizophrenic. Sandoz subsequently decided to promote LSD as a research drug for experimental investigations of schizophrenia, and especially its possible biochemical basis. But, somewhat confusingly, the company also did something else: they suggested that the psychoanalysts also take a look at the drug, because there was evidence that it gave people access to the unconscious contents of their minds and could sometimes be therapeutic.

So which was it: a path to madness or a path to health? A drug for the biologists to study, or a tool for the psychoanalysts to employ? In this seminar, I will track the contradictions and ambiguities structuring mid-20th-century clinical conversations about the meaning and uses of psychedelics. An important goal will be to identify the legacies and unfinished business from that earlier era and show the ways some of them, perhaps unconsciously, are shaping current efforts and conversations.



CE information will be sent to all attendees the week after the event.

Refunds available only with pre-event cancellation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Psychoanalytic Association and the Cleveland Psychoanalytic Center. The American Psychoanalytic Association is accredited by the ACCME to provide continuing medical education for physicians.”

The American Psychoanalytic Association designates this Live Activity for a maximum of 11.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The State of Ohio Counselor, Social Worker and Marriage & Family Therapist Board has designated The Cleveland Psychoanalytic Center as Approved Provider RCS109510.  This event provides one credit per hour of Continuing Professional Education to counselors and social workers only.

The Cleveland Psychoanalytic Center is approved by the Ohio Psychological Association-MCE Program to offer continuing education for psychologists.  The Cleveland Psychoanalytic Center as Approved Provider 18PO-341019020, maintains responsibility for the program.  This event provides one credit per hour of Continuing Professional Education to psychologists. Ohio CSWMFTB accepts this approval for licensees.

IMPORTANT DISCLOSURE INFORMATION FOR ALL LEARNERS: None of the planners and presenters for this educational activity have relevant financial relationship(s)* to disclose with ineligible companies* whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
*Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
-Updated July 2021-



Cleveland Psychoanalytic Center is a 501(c)3 non-profit organization.    2460 Fairmount Blvd, Suite 312. Cleveland OH 44106 216-229-5959

Powered by Wild Apricot Membership Software